Viewing Study NCT04627012

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-01-28 @ 4:06 AM
Study NCT ID: NCT04627012
Status: COMPLETED
Last Update Posted: 2024-03-06
First Post: 2020-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Anti-PD1 Antibody View
None Liver Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tislelizumab View
None Lenvatinib View
None Toripalimab View
None Sintilimab View
None Camrelizumab View
None Keytruda View
None Opdivo View